These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
996 related articles for article (PubMed ID: 28933629)
1. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629 [TBL] [Abstract][Full Text] [Related]
2. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334 [TBL] [Abstract][Full Text] [Related]
3. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development. He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273 [TBL] [Abstract][Full Text] [Related]
5. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages. Ke P; Shao BZ; Xu ZQ; Wei W; Han BZ; Chen XW; Su DF; Liu C PLoS One; 2016; 11(9):e0155076. PubMed ID: 27611972 [TBL] [Abstract][Full Text] [Related]
6. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588 [TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement. Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788 [TBL] [Abstract][Full Text] [Related]
12. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942 [TBL] [Abstract][Full Text] [Related]
13. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy. Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335 [TBL] [Abstract][Full Text] [Related]
14. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway. Huang Y; Wan T; Pang N; Zhou Y; Jiang X; Li B; Gu Y; Huang Y; Ye X; Lian H; Zhang Z; Yang L J Cell Physiol; 2019 Nov; 234(11):21224-21234. PubMed ID: 31032942 [TBL] [Abstract][Full Text] [Related]
16. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. Liu W; Bai F; Wang H; Liang Y; Du X; Liu C; Cai D; Peng J; Zhong G; Liang X; Ma C; Gao L J Immunol; 2019 Aug; 203(4):990-1000. PubMed ID: 31263038 [TBL] [Abstract][Full Text] [Related]
17. Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway. Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S Biomed Pharmacother; 2020 Aug; 128():110216. PubMed ID: 32497863 [TBL] [Abstract][Full Text] [Related]
18. TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation. Shi Y; Su W; Zhang L; Shi C; Zhou J; Wang P; Wang H; Shi X; Wei S; Wang Q; Auwerx J; Schoonjans K; Yu Y; Pan R; Zhou H; Lu L Front Immunol; 2020; 11():609060. PubMed ID: 33692776 [TBL] [Abstract][Full Text] [Related]
19. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling. Pu Z; Liu Y; Li C; Xu M; Xie H; Zhao J Am J Chin Med; 2020; 48(7):1693-1713. PubMed ID: 33202149 [TBL] [Abstract][Full Text] [Related]
20. X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy. Zhou W; Liu X; Cheng K; Zhang X; Lu J; Hu R Exp Cell Res; 2017 Nov; 360(2):320-327. PubMed ID: 28942022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]